ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Biomedical Panel To Hear Public At Sept. Meeting

July 11, 1975

Continuing Resolution Averts Shutdown; Locks in Sequestration Cuts for NIH, NCI

March 22, 2013

Be More Aggressive On National Issues, ASCO Urged

May 20, 1977

NCI Must Build a Research Community In Pancreatic Cancer, Review Groups Says.

March 9, 2001

DCPC Board Okays Reissuance Of RFA for Chemoprevention Clinical Trials

May 20, 1988

ACS Board allocated $37.5 Million to Research; More Coming

February 20, 1987